U.S. markets open in 9 hours 24 minutes
  • S&P Futures

    4,071.50
    +12.75 (+0.31%)
     
  • Dow Futures

    33,607.00
    +99.00 (+0.30%)
     
  • Nasdaq Futures

    13,049.25
    +50.75 (+0.39%)
     
  • Russell 2000 Futures

    2,142.00
    +10.50 (+0.49%)
     
  • Crude Oil

    65.44
    -0.64 (-0.97%)
     
  • Gold

    1,816.80
    -6.00 (-0.33%)
     
  • Silver

    27.11
    -0.13 (-0.47%)
     
  • EUR/USD

    1.2080
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.6950
    +0.0710 (+4.37%)
     
  • Vix

    27.59
    +5.75 (+26.33%)
     
  • GBP/USD

    1.4061
    +0.0004 (+0.03%)
     
  • USD/JPY

    109.7070
    +0.0470 (+0.04%)
     
  • BTC-USD

    50,828.41
    -7,018.68 (-12.13%)
     
  • CMC Crypto 200

    1,389.02
    -174.82 (-11.18%)
     
  • FTSE 100

    7,004.63
    +56.64 (+0.82%)
     
  • Nikkei 225

    27,690.33
    -457.18 (-1.62%)
     

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLUE, MPLN and VRM

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / April 9, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

bluebird bio, Inc. (NASDAQ:BLUE)

Investors Affected: May 11, 2020 - November 4, 2020

A class action has commenced on behalf of certain shareholders in bluebird bio, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) data supporting bluebird's BLA submission for LentiGlobin for SCD was insufficient to demonstrate drug product comparability; (ii) Defendants downplayed the foreseeable impact of disruptions related to the COVID-19 pandemic on the Company's BLA submission schedule for LentiGlobin for SCD, particularly with respect to manufacturing; (iii) as a result of all the foregoing, it was foreseeable that the Company would not submit the BLA for LentiGlobin for SCD in the second half of 2021; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/bluebird-bio-inc-loss-submission-form/?id=14524&from=1

Multiplan Corporation F/K/A Churchill Capital Corp. Iii (NYSE:MPLN)

Investors Affected: July 12, 2020 - November 10, 2020

A class action has commenced on behalf of certain shareholders in Multiplan Corporation F/K/A Churchill Capital Corp Iii. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) MultiPlan was losing tens of millions of dollars in sales and revenues to Naviguard, a competitor created by one of MultiPlan's largest customers, UnitedHealthcare, which threatened up to 35% of the Company's sales and 80% of its levered cash flows by 2022; (b) sales and revenue declines in the quarters leading up to the Merger were not due to "idiosyncratic" customer behaviors as represented, but rather due to a fundamental deterioration in demand for MultiPlan's services and increased competition, as payors developed competing services and sought alternatives to eliminating excessive healthcare costs; (c) MultiPlan was facing significant pricing pressures for its services and had been forced to materially reduce its take rate in the lead up to the Merger by insurers, who had expressed dissatisfaction with the price and quality of MultiPlan's services and balanced billing practices, causing the Company's to cut its take rate by up to half in some cases; (d) as a result of (a)-(c) above, MultiPlan was set to continue to suffer from revenues and earnings declines, increased competition and deteriorating pricing dynamics following the Merger; (e) as a result of (a)-(d) above, MultiPlan was forced to seek continued revenue growth and to improve its competitive positioning through pricey acquisitions, including through the purchase of HST for $140 million at a premium price from a former MultiPlan executive only one month after the Merger; and (f) as a result of (a)-(e) above, Churchill III investors had grossly overpaid for the acquisition of MultiPlan in the Merger, and MultiPlan's business was worth far less than represented to investors.

Shareholders may find more information at https://securitiesclasslaw.com/securities/multiplan-corporation-f-k-a-churchill-capital-corp-iii-loss-submission-form/?id=14524&from=1

Vroom, Inc. (NASDAQ:VRM)

Investors Affected: June 9, 2020 - March 3, 2021

A class action has commenced on behalf of certain shareholders in Vroom, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Vroom had not demonstrated that it was able to control and scale growth in respect to its salesforce to meet the demand for its products; (2) as a result, the Company was forced to discount aged inventory to move through its retail channels or liquidated in its wholesale channels; (3) as a result, the ecommerce gross profit per unit was reasonably likely to decline; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/vroom-inc-loss-submission-form/?id=14524&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm



View source version on accesswire.com:
https://www.accesswire.com/639661/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-BLUE-MPLN-and-VRM